{
    "Trade/Device Name(s)": [
        "Elecsys HSV-1 IgG (08948844160)"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K220923",
    "Predicate Device Reference 510(k) Number(s)": [
        "K120625"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MYF",
        "MXJ"
    ],
    "Summary Letter Date": "March 29, 2022",
    "Summary Letter Received Date": "March 31, 2022",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3305",
        "866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes Simplex Virus Serological Assays",
        "Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1"
    ],
    "Analyte Class(es)": [
        "virology",
        "serology",
        "immunology"
    ],
    "Analyte(s)": [
        "HSV-1 IgG"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium-heparin plasma",
        "K2-EDTA plasma",
        "K3-EDTA plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "cobas e immunoassay analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys HSV-1 IgG immunoassay for qualitative detection of HSV-1 IgG in human serum and plasma on cobas e analyzers",
    "Indications for Use Summary": "Immunoassay for in vitro qualitative determination of IgG antibodies to HSV-1 in serum and plasma specimens, intended for sexually active individuals and expectant mothers as an aid in presumptive diagnosis of HSV-1 infection, not for blood/plasma donor screening or pediatric/POC use",
    "fda_folder": "Microbiology"
}